According to a report by The Times of India on September 25th, the Council of Scientific and Industrial Research (CSIR) in India has developed a new variety of tobacco with nicotine content 40%-50% lower than regular tobacco, aimed at reducing the impact on public health.
According to N Kalaiselvi, the Director General of the Council of Scientific and Industrial Research (CSIR), India, a new variety of tobacco has been developed by a research institution under the guidance of Prime Minister Narendra Modi. This tobacco variant has a reduced nicotine content of 40%-50% compared to regular tobacco, aiming to minimize its impact on health. "Therefore, even if consumers use tobacco, its effects on health will be minimized as much as possible," stated Kalaiselvi.
Prime Minister Modi has previously proposed the possibility of developing such a type of tobacco, and the laboratory has successfully developed this new variety of tobacco to mitigate its effects on health. Karaseelvi stated that the laboratory is continuing its efforts to further reduce its impact by 60% - 70%.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
